Marshall Wace LLP Boosts Stock Position in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Marshall Wace LLP increased its stake in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 251.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 192,726 shares of the company's stock after buying an additional 137,853 shares during the period. Marshall Wace LLP owned 0.07% of Ryan Specialty worth $12,365,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in RYAN. Barclays PLC raised its position in shares of Ryan Specialty by 1.1% during the third quarter. Barclays PLC now owns 1,641,743 shares of the company's stock worth $108,994,000 after purchasing an additional 17,267 shares during the period. Virtu Financial LLC bought a new stake in shares of Ryan Specialty during the third quarter worth approximately $263,000. Wilmington Savings Fund Society FSB bought a new position in shares of Ryan Specialty during the third quarter worth approximately $193,000. Tidal Investments LLC increased its holdings in Ryan Specialty by 30.4% in the 3rd quarter. Tidal Investments LLC now owns 12,255 shares of the company's stock valued at $814,000 after buying an additional 2,858 shares during the period. Finally, Principal Financial Group Inc. increased its position in Ryan Specialty by 148.9% during the 3rd quarter. Principal Financial Group Inc. now owns 851,704 shares of the company's stock worth $56,545,000 after purchasing an additional 509,548 shares in the last quarter. Institutional investors and hedge funds own 84.82% of the company's stock.

Analyst Ratings Changes

RYAN has been the subject of a number of analyst reports. Barclays lowered their price objective on Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating for the company in a research report on Friday, April 11th. TD Cowen started coverage on Ryan Specialty in a research note on Thursday, April 10th. They issued a "buy" rating and a $89.00 target price for the company. Royal Bank of Canada lowered their target price on shares of Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating on the stock in a report on Friday, February 21st. UBS Group upped their target price on shares of Ryan Specialty from $82.00 to $84.00 and gave the stock a "buy" rating in a research note on Wednesday, February 26th. Finally, Keefe, Bruyette & Woods dropped their price target on Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating on the stock in a report on Wednesday, April 9th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat, Ryan Specialty has a consensus rating of "Hold" and an average price target of $75.67.

Insider Activity

In other Ryan Specialty news, EVP Brendan Martin Mulshine sold 30,000 shares of the business's stock in a transaction that occurred on Friday, March 14th. The stock was sold at an average price of $69.30, for a total transaction of $2,079,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Nicholas Dominic Cortezi sold 31,409 shares of the stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $65.64, for a total value of $2,061,686.76. Following the transaction, the director now directly owns 2,697 shares of the company's stock, valued at $177,031.08. The trade was a 92.09 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 96,409 shares of company stock valued at $6,424,437 in the last three months. 11.10% of the stock is currently owned by corporate insiders.

Ryan Specialty Trading Up 0.3 %

Shares of RYAN traded up $0.18 during trading hours on Thursday, reaching $69.60. 782,662 shares of the company traded hands, compared to its average volume of 953,175. The firm has a market cap of $18.23 billion, a price-to-earnings ratio of 100.87, a PEG ratio of 1.19 and a beta of 0.66. Ryan Specialty Holdings, Inc. has a 12-month low of $48.48 and a 12-month high of $77.16. The stock's fifty day moving average price is $70.53 and its 200 day moving average price is $69.00. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40.

Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its quarterly earnings data on Thursday, February 20th. The company reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.47 by ($0.02). The company had revenue of $663.53 million for the quarter, compared to analyst estimates of $658.80 million. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. Sell-side analysts forecast that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current year.

Ryan Specialty Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Tuesday, March 4th were issued a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 0.69%. The ex-dividend date was Tuesday, March 4th. This is a boost from Ryan Specialty's previous quarterly dividend of $0.11. Ryan Specialty's dividend payout ratio (DPR) is 69.57%.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.